Novus Biologicals products are now on bio-techne.com

Recombinant Human LIGHT/TNFSF14 Protein, CF

Images

 
Recombinant Human LIGHT/TNFSF14 (Catalog # 664-LI/CF) stimulates cell proliferation in HUVEC human umbilical vein endothelial cells. The ED50 is 1-4 ng/mL.
1 µg/lane of Recombinant Human LIGHT/TNFSF14 (Catalog # 664-LI/CF) was resolved with SDS-PAGE under reducing (R) conditions and visualized by silver staining, showing a band at 25 kDa.

Product Details

Summary
Reactivity HuSpecies Glossary
Applications Bioactivity
Format
Carrier-Free

Order Details

View Available Formulations
Catalog# & Formulation Size Price
Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

Recombinant Human LIGHT/TNFSF14 Protein, CF Summary

Details of Functionality
Measured in a cell proliferation assay using HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci. USA 87:1323. The ED50 for this effect is 0.3-3 ng/mL.
Source
Mouse myeloma cell line, NS0-derived human LIGHT/TNFSF14 protein
Met 10-His tag GGGSGGGSGGGSIEGR Human Light
(Asp74-Val240)
Accession # O43557
N-terminus C-terminus
Accession #
N-terminal Sequence
Met
Protein/Peptide Type
Recombinant Proteins
Gene
TNFSF14
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

Dilutions
  • Bioactivity2
Theoretical MW
20.9 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
25 kDa, reducing conditions
Publications
Read Publications using
664-LI/CF in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Reconstitution Instructions
Reconstitute at 100 μg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human LIGHT/TNFSF14 Protein, CF

  • CD258 antigen
  • CD258
  • delta transmembrane LIGHT
  • Herpes virus entry mediator ligand
  • Herpesvirus entry mediator ligand
  • HVEM-L
  • HVEMLherpesvirus entry mediator-ligand
  • ligand for herpesvirus entry mediator
  • LIGHT
  • LIGHTherpesvirus entry mediator A
  • LTg
  • TNFSF14
  • TR2
  • tumor necrosis factor (ligand) superfamily, member 14
  • tumor necrosis factor ligand superfamily member 14
  • tumor necrosis factor receptor-like 2
  • tumor necrosis factor superfamily member LIGHT

Background

Human LIGHT is a type II membrane protein that is a member of the TNF superfamily. LIGHT is an acronym which stands for "is homologous to lymphotoxins, exhibits inducible expression, and competes with HSV glycoprotein D for HVEM, a receptor expressed by T lymphocytes". LIGHT has also been called HVEM-L and LT-gamma . Under the new TNF nomenclature, it is called TNFSF14. LIGHT is a 240 amino acid (aa) protein that contains a 37 aa cytoplasmic domain, a 22 aa transmembrane region, and a 181 aa extracellular domain. Similar to other TNF ligand family members, LIGHT is predicted to assemble as a homotrimer. LIGHT is produced by activated T cells and was first identified by its ability to compete with HSV glycoprotein D for HVEM binding. LIGHT has also been shown to bind to the lymphotoxin beta receptor (LT beta R) and the decoy receptor (DcR3/TR6). LIGHT overexpression in tumor cells induces apoptosis, which can be enhanced by IFN-gamma . The full roles of LIGHT remain to be elucidated.

  1. Mauri, D.N. et al. (1998) Immunity 8:21.
  2. Zhai, Y. et al. (1998) J. Clin. Invest. 102:1142.
  3. Harrop, J.A. et al. (1998) J. Biol. Chem. 273:27548.
  4. Yu, K-Y. et al. (1999) J. Biol. Chem. 274:13733.

Customers Who Viewed This Item Also Viewed...

NBP2-59690
Species: Am, Av, Fi, Ma, Ze
Applications: ELISA, ICC/IF, IHC, IHC-Fr, IP, WB
H00342184-M07
Species: Hu
Applications: ELISA, ICC/IF, WB
AF3398
Species: Hu, Mu, Rt
Applications: ICC, KO, Simple Western, WB
AF6989
Species: Mu
Applications: IHC
NBP1-86616
Species: Hu
Applications: IHC, IHC-P, WB
NBP2-58917
Species: Hu
Applications: IHC, IHC-P, WB
NBP2-60655
Species: Hu
Applications: ICC/IF, IHC, IHC-P, WB
NBP3-03109
Species: Hu, Mu
Applications: IHC, IHC-P, WB
AF1445
Species: Mu, Rt
Applications: ELISA(Cap), ELISA(Det), ELISA(Sta), IHC, Neut, Simple Western, WB
MAB1455
Species: Hu
Applications: CyTOF-ready, Dual ISH-IHC, ICC, IHC, ICFlow, Simple Western, WB
NBP1-88927
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P, WB
NBP2-38770
Species: Hu, Mu
Applications: IHC-P, WB
NBP2-50037
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, KO, WB
NBP1-89396
Species: Hu
Applications: ICC/IF, IHC, IHC-P, WB
NB300-581
Species: Am, Ca, Gp, Hu, Mu, Po, Rb, Rt, Sh
Applications: Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
NBP3-35145
Species: Hu, Mu, Rt
Applications: ELISA, ICC/IF, IHC, IHC-P, WB
NBP1-30475
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P, IP, WB
AF1936
Species: Hu
Applications: IP, WB
664-LI/CF
Species: Hu
Applications: Bioactivity

Publications for LIGHT/TNFSF14 (664-LI/CF)(18)

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 3 applications: Bioassay, Cell Culture, Surface Plasmon Resonance (SPR.


Filter By Application
Bioassay
(16)
Cell Culture
(1)
Surface Plasmon Resonance (SPR
(1)
All Applications
Filter By Species
Human
(18)
Mouse
(1)
All Species
Showing Publications 1 - 10 of 18. Show All 18 Publications.
Publications using 664-LI/CF Applications Species
SK Heo, Y Choi, YK Jeong, LJ Ju, HM Yu, DK Kim, HJ Seo, YJ Lee, J Cheon, S Koh, YJ Min, EK Noh, JC Jo LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells PLoS ONE, 2021-02-19;16(2):e0247368. 2021-02-19 [PMID: 33606781] (Bioassay, Human) Bioassay Human
Jang H, Park S, Kim J, Kim J, Kim S, Cho S, Park S, Park B, Kim S, Kim J The Tumor Suppressor, p53, Negatively Regulates Non-Canonical NF-kappaB Signaling through miRNAInduced Silencing of NF-kappaB-Inducing Kinase. Mol Cells, 2020-01-31;43(1):23-33. 2020-01-31 [PMID: 31870133] (Bioassay, Human) Bioassay Human
S An, I Raju, B Surenkhuu, JE Kwon, S Gulati, M Karaman, A Pradeep, S Sinha, C Mun, S Jain Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies Ocul Surf, 2019-04-06;0(0):. 2019-04-06 [PMID: 30965123] (Bioassay, Human) Bioassay Human
KH Kim, H Choi, HJ Kim, TR Lee TNFSF14 inhibits melanogenesis via NF-kB signaling in melanocytes Cytokine, 2018-05-03;110(0):126-130. 2018-05-03 [PMID: 29730385] (Bioassay, Human) Bioassay Human
R da Silva A, AK Mehta, L Madge, J Tocker, M Croft TNFSF14 (LIGHT) Exhibits Inflammatory Activities in Lung Fibroblasts Complementary to IL-13 and TGF-β Front Immunol, 2018-03-19;9(0):576. 2018-03-19 [PMID: 29616048] (Cell Culture, Human) Cell Culture Human
AW Clarke, L Poulton, D Shim, D Mabon, D Butt, M Pollard, V Pande, J Husten, J Lyons, C Tian, AG Doyle An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease MAbs, 2018-03-05;0(0):1-43. 2018-03-05 [PMID: 29436901] (Surface Plasmon Resonance (SPR, Human) Surface Plasmon Resonance (SPR Human
S Abadpour, B Halvorsen, A Sahraoui, O Korsgren, P Aukrust, H Scholz Interleukin-22 reverses human islet dysfunction and apoptosis triggered by hyperglycemia and LIGHT J. Mol. Endocrinol., 2018-01-12;0(0):. 2018-01-12 [PMID: 29330151] (Bioassay, Human) Bioassay Human
X Yuan, Y Gu, X Lai, Q Gu LIGHT is increased in patients with coronary disease and regulates inflammatory response and lipid metabolism in oxLDL-induced THP-1 macrophages Biochem. Biophys. Res. Commun., 2017-06-19;0(0):. 2017-06-19 [PMID: 28642135] (Bioassay, Human) Bioassay Human
A TNFRSF14-Fc?RI-mast cell pathway contributes to development of multiple features of asthma pathology in mice Nat Commun, 2016-12-16;7(0):13696. 2016-12-16 [PMID: 27982078] (Bioassay, Human) Bioassay Human
LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells PLoS ONE, 2016-11-11;11(11):e0166589. 2016-11-11 [PMID: 27835685] (Bioassay, Human) Bioassay Human
Show All 18 Publications.

Reviews for LIGHT/TNFSF14 (664-LI/CF) (0)

There are no reviews for LIGHT/TNFSF14 (664-LI/CF). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for LIGHT/TNFSF14 (664-LI/CF) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional LIGHT/TNFSF14 Products

Blogs on LIGHT/TNFSF14

There are no specific blogs for LIGHT/TNFSF14, but you can read our latest blog posts.
Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Human LIGHT/TNFSF14 Protein, CF and receive a gift card or discount.

Bioinformatics

Gene Symbol TNFSF14
Uniprot